BiotechTube
Home/OS Therapies/Paul Romness
PR

Paul Romness

Chair, Chief Executive Officer, President

OS Therapies

Therapeutic Areas

OncologyRare Diseases

OS Therapies Pipeline

DrugIndicationPhase
OST-HER2Osteosarcoma (HER2+)Phase 1

Leadership Team at OS Therapies

RP
Robert Petit
Chief Medical & Scientific Officer, Founding Scientist (OST-HER2)
GC
Gerald Commisiong
Chief Business Officer
JW
Jutta Wanner
Advisor, Founding Scientist (OST-tADC)
JD
Jack Doll
Chief of Staff
CA
Chris Acevedo
Chief Financial Officer
View full OS Therapies profile